Pharma Journalist -

SMi Group reports: The agenda and speaker line-up for the launch of Medical Devices and IVD Conference 2021 which will convene on 15th and 16th November has been released.  SMi Group…
Read More...

Indivior PLC, announced that it is extending its leadership position in substance use disorder ("SUD") treatment by expanding into the under treated cannabis-related disorders,…
Read More...

Icosavax, Inc. announced the first subjects have been dosed with IVX-411, a virus-like particle (VLP) displaying the SARS-CoV-2 receptor-binding domain (RBD), in a Phase 1/2 clinical…
Read More...

BioCelerate, a subsidiary of TransCelerate BioPharma Inc. that focuses on identifying and developing pragmatic and tangible solutions to improve efficiencies in nonclinical research,…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in…
Read More...

argenx SE a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced it will regain worldwide rights to its…
Read More...

Samyang Holdings signed an MOU to co-develop a vaccine for COVID-19 with “mCureX (CEO: Hong Sun-woo),” a subsidiary of a “OliX Pharmaceuticals (CEO: Lee Dong-ki),” a pharmaceutical…
Read More...

Biogen and Eisai, Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-avwa) as the first and only Alzheimer’s…
Read More...

Ascletis Pharma Inc. announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to…
Read More...

Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...